Key result
Elderly outpatients newly prescribed digoxin were without CHF medication for an average of 111 days during the first year, with only 10% having daily medication available for the entire year.
Cohort (n=7,247)
Elderly patients newly prescribed digoxin for heart failure exhibit high rates of noncompliance, being without medication for nearly a third of the first year of therapy.
Answers are grounded in this paper and cite their sources.
Substantial digoxin nonadherence in elderly HF outpatients may affect outcomes; leaves open whether targeted interventions improve persistence or prognosis.
Background: Noncompliance with long-term medication regimens, such as those employed in the treatment of congestive heart failure (CHF), has been found to be approximately 50%. However, no evaluation has been performed on a population-based cohort of elderly patients beginning the use of digoxin and followed up longitudinally for an extended observation period. Methods: To study patterns of medication compliance, we conducted a retrospective follow-up of 7247 outpatients aged 65 to 99 years newly prescribed digoxin between 1981 and 1991, with the use of the complete prescription claims file of the New Jersey Medicaid program. Noncompliance was measured in terms of the number of days during the 12-month period after an initial digoxin prescription in which no CHF medication was available to the patient. Results: Patients started on a regimen of digoxin were without digoxin or any other common alternative CHF drug for an average of 111 of the 365 days of follow-up. Only 10% of the population filled enough prescriptions to have daily CHF medication available for the entire year of follow-up. Compliance rates were higher in patients over 85 years of age, women, those taking multiple medications, and those with hospital or nursing home stays before the initiation of therapy. Conclusions: A large proportion of patients who begin digoxin therapy end CHF therapy or consume substantially less medication than expected in the first year of therapy. Such high rates of cessation could represent an important impediment to effective CHF therapy. (Arch Intern Med. 1994;154:433-437)
No takes yet. Share an insight, caveat, or question.
M. Monane (1994) conducted a cohort in congestive heart failure (n=7,247). Digoxin therapy was evaluated on Number of days during the 12-month period after an initial digoxin prescription in which no CHF medication was available. Elderly outpatients newly prescribed digoxin were without CHF medication for an average of 111 days during the first year, with only 10% having daily medication available for the entire year.
Synapse has enriched 10 related papers. Consider them for comparative context: